For the Inventor, By the Inventor

Enter inventor name

Acton, MA, United States of America

Qing Tang

USPTO Granted Patents = 45 (Patent Applications = 13)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 7.6

ph-index = 15

Forward Citations = 683(Granted Patents)

Location History:

Cambridge, MA (US) (2003 - 2007)
Winchester, MA (US) (2008)
Acton, MA (US) (2007 - 2023)
Boxborough, MA (US) (2023 - 2024)

Company Filing History:

43 out of 1,151

Vertex Pharmaceuticals, Inc.

Merck Patent Gmbh

Cellarity, Inc.

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

DCN-1 Modulating Compounds

Alpha-1 Antitrypsin Modulators

DNA-PK Inhibitors

Antiproliferation Compounds

Pyrrole Inhibitors

ERK Protein Kinase Inhibitors

c-MET Protein Kinase Inhibitors

Serine Protease Inhibitors

Heteroaryl Compounds

Prodrugs of Kinase Inhibitors

Heterocyclic Inhibitors

Pyrazole-Derived Kinase Inhibitors

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2025-12-23),

2. 12473285 - DCN-1 modulating compounds and methods of use thereof (2025-11-18),

3. 12435087 - Modulators of DCN-1 and methods of use thereof (2025-10-07),

4. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

5. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors (2025-03-18),

6. 12195453 - Antiproliferation compounds and uses thereof (2025-01-14),

7. 12005127 - DNA-PK inhibitors (2024-06-11),

8. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

9. 11813267 - DNA-PK inhibitors (2023-11-14),

10. RE49500 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto (2023-04-24),

11. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

12. 11440907 - Antiproliferation compounds and uses thereof (2022-09-13),

13. 10973830 - Substituted quinoxaline DNA-PK inhibitors (2021-04-13),

14. 10815225 - Antiproliferation compounds and uses thereof (2020-10-27),

15. RE48266 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto (2020-10-19),

Title: Inventor Qing Tang: Pioneering Innovations in Acton

Introduction: Qing Tang, a visionary inventor based in Acton, MA, is renowned for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Qing Tang holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Qing Tang has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the industry.

Collaborations: Throughout her career, Qing Tang has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all her projects.

Conclusion: Qing Tang's passion for innovation and her relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…